Top section
Top section
Offer came as markets recovered and volatility fell
Submarine mast maker's IPO raised €132.8m
Broaching the delicate subject with your boss of being asked to keep too many plates spinning
More articles
More articles
More articles
-
Autolus Therapeutics, the UK biopharmaceutical company focused on T cell therapies for cancer, is raising additional capital on the Nasdaq. -
Chinese regulators have made a long overdue move to reduce the number of boards at the Shenzhen stock exchange. That points to a greater commitment towards streamlining the country’s sometimes confounding capital markets.
-
China-based Betta Pharmaceuticals, a developer of cancer treatments, is planning a Hong Kong IPO, having filed draft paperwork with the city’s stock exchange on Monday.
-
Hong Kong’s Securities and Futures Commission (SFC) is planning to introduce new rules that will require syndicate teams on bond and equity deals to be fixed earlier and brokers to disclose their fee structures, moves that are aimed at improving transparency in the city's capital markets and hold banks more accountable for their transactions.
-
Equity investors have maintained a focus on gaining exposure to tech stocks so far this year in the primary market, dispelling fears that high-growth digital companies might lose out to cyclical, value stocks that might benefit from the reopening of economies from the Covid-19 pandemic.
-
German stocks have continued to be among the best performing in Europe in 2021, fuelling momentum in the country’s equity capital markets.
Sub-sections
shared comment list
